Document is current
Any future updates will be listed below
-
Authors
van der Krogt, Laura
Carter, Jenny
Dalla Valle, Giorgia
Suff, Natalie
Story, Lisa
Tribe, Rachel M.
Shennan, Andrew
-
Funding
Funding for this research was provided by:
Action Medical Research (GN2967)
Action Medical Research (GN2967)
Borne (GN2967)
Borne (GN2967)
- License Information
-
More Information
Article History
Received: 17 December 2024
Accepted: 11 February 2026
First Online: 20 February 2026
Declarations
:
: The study received regulatory approval from the following bodies: NHS North West – Preston Research Ethics Committee Favourable Opinion and HRA Approval (REC reference: 24/NW/0093). Before any site can enrol patients into the study, the Chief Investigator/Principal Investigator or designee will ensure that the appropriate regulatory approvals have been issued, and NHS Confirmations of Capacity and Capability and Sponsor green lights are in place.All participants will be provided with participant information sheets and be asked to give informed written consent, in accordance with principles outlined in Good Clinical Practice. Participants may withdraw from the trial without it affecting their ongoing care. This option will be discussed at the time of consent.
: Not applicable. This paper does not contain any individual person’s data in any form.
: The authors declare no competing interests.
